MTOR and cancer: In addition, prior research demonstrated the critical role played by TGF-β-induced signaling via the PI3K-PKBmammalian target of rapamycin (mTOR) pathway in the progression of EMT, suggesting that mTOR may be a good candidate for use as a target in the fight against cancer metastasis [130].